Drug intelligence / Profile preview

aripiprazole + sertraline

Development stage
Phase 1
Lead developer
Taiho Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

A combination formulation of aripiprazole (an atypical antipsychotic) and sertraline (a selective serotonin reuptake inhibitor) developed for the treatment of major depressive disorder and bipolar depression. It combines serotonin reuptake inhibition from sertraline with modulation of dopamine and serotonin receptors from aripiprazole.

Other names
ASC-01ASC01ASC 01aripiprazole/sertraline combination drugsertraline/aripiprazole
02

Targets

SERT (Sodium-dependent serotonin transporter)ABCB1 (P-glycoprotein)HTR2A (Serotonin receptor 5-HT2A)SIGMAR1 (Sigma non-opioid intracellular receptor 1)ADRA1A (α1A)DAT (Dopamine plasma membrane transport protein)DRD2 (Dopamine D2 Receptor)NET (Norepinephrine Transporter)HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))

Beyond the preview

Go deeper on aripiprazole + sertraline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on aripiprazole + sertraline.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call